Foscarnet
From Wikipedia, the free encyclopedia
Foscarnet
|
|
Systematic (IUPAC) name | |
phosphonomethanoic acid | |
Identifiers | |
CAS number | 63585-09-1 |
ATC code | J05AD01 |
PubChem | 3415 |
DrugBank | APRD00669 |
Chemical data | |
Formula | CH3O5P |
Mol. weight | 126.005 g/mol 300.1 g/mol (foscarnet trisodium hexahydrate) |
Pharmacokinetic data | |
Bioavailability | NA |
Protein binding | 14-17% |
Metabolism | ? |
Half life | 3.3-6.8 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. | |
Legal status | |
Routes | Intravenous |
Foscarnet (marketed by AstraZeneca as foscarnet sodium under the trade name Foscavir®) is an antiviral medication used to treat herpes viruses, including cytomegalovirus (CMV) and herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2). It is particularly used to treat CMV retinitis.
[edit] Mechanism of action
Foscarnet is an organic analog of inorganic pyrophosphate that selectively inhibits the pyrophosphate binding site on viral DNA polymerases at concentrations that do not affect human DNA polymerases. Because foscarnet is not activated by thymidine kinase, it maintains activity in some viruses which have lost thymidine kinase activity to gain resistance to aciclovir or ganciclovir. Therefore, foscarnet is often used in aciclovir- or ganciclovir-resistant disease. However, acyclovir or ganciclovir resistant mutants with alterations in viral DNA polymerase may be resistant to foscarnet.
[edit] Administration
Intravenous only
[edit] Side effects
Antivirals (primarily J05A, also S01AD and D06BB) edit | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|